Skip to main content
OMRON Connect compatible

Complete

HEM-7530T-E

Blood Pressure Monitors

5 years of warranty *

Automatic blood pressure monitor with single lead ECG

Find a store
Device Type Blood Pressure Monitor and 1-Lead ECG Monitor
Weight of Device 0.55
Cuff Type Easy Cuff 22-42 cm
Cuff Wrap Guide Yes
Memory management 90 Readings
Irregular Heartbeat Detection Yes
Body Movement Detection Yes
Validation Clinical Validation
AFib detection Yes
Easy High Blood Pressure Indicator No
Blood Pressure Level Indicator No
Advanced Positioning Sensor No
Intellisense Yes
Stroke Prevention No
Storage Yes
Averaging Function Yes
Connected Yes
Compatible Mobile App Compatible with OMRON connect app
Item dimensions (mm): 232 x 123 x 989

Publications

Managing and identifying AF can be difficult for both patients and healthcare providers because many patients with AF are unable to recognize and distinguish symptoms associated with AF from other conditions, which can impede timely treatment and put them at risk for complications.

Read all publications for OMRON Complete

Features

  • AFib is associated with a 5x greater risk of stroke and heart failure, so it’s important to detect and begin treatment early.

  • Unfortunately, AFib can show no symptoms and may not be present during doctor’s visits because the episodes come and go, which means it’s often left undiagnosed.

  • Given how serious AFib complications can be, it is important for those who may be at risk to routinely record electrocardiogram (ECG) measurements, according to current medical guidelines.

  • OMRON Complete is NOT intended for diagnosis of any cardiac conditions without a healthcare professional. Consult a healthcare professional prior to use.

 

References

1. Complications: atrial fibrillation. NHS. Reviewed April 24, 2018. Accessed November 2, 2020. https://www.nhs.uk/conditions/atrial-fibrillation/complications.

2. Gómez-Outes A, Lagunar-Ruíz J, Terleira-Fernández A, Calvo-Rojas G, Suárez-Gea ML, Vargas-Castrillón E. Causes of death in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2016;68(23):2508-2521.

3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857-867.

4. Esato M, Chun Y, An Y, et al. Clinical impact of asymptomatic presentation status in patients with paroxysmal and sustained atrial fibrillation: the Fushimi AF Registry. Chest. 2017;152(6):1266-1275.

5. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;ehaa612. doi:10.10/93/eurheartj/ehaa612.

6. Senoo K., et al. Diagnostic Value of Atrial Fibrillation by Built-in Electrocardiogram Technology in a Blood Pressure Monitor. 2020. J-STAGE, 2(7): 345-350

Select a maximum of 2 products.